PMID: 2126146Jan 1, 1990Paper

Treatment of chronic viral hepatitis anno 1990

Scandinavian Journal of Gastroenterology. Supplement
S W Schalm

Abstract

Alpha-interferon has emerged as the most effective agent for the treatment of chronic hepatitis when active replication of virus B, C, or D is present. Exogenous administration of human alpha-interferon, now possible through modern large-scale production methods, is associated with suppression of virus in blood. Amelioration of liver disease occurs in 35% of patients with hepatitis B virus and in 50% with hepatitis C virus with interferon doses of 30 and 10 MU per week, respectively, for 16-26 weeks; after therapy, persistent normalization of serum alanine aminotransferase is observed in 35% and 27%, respectively. Similar results have now also been reported for chronic hepatitis D. Enhanced response rates (greater than 50%) may be obtained by prolonged intermittent interferon therapy. Combination of interferon with another 'antiviral' agent (vidarabine, acyclovir, prednisone) has not increased therapeutic efficacy. Alpha-interferon induces side effects such as fatigue, flu-like syndrome, myalgia, and changes in mood and granulocytes. Patients with decompensated cirrhosis are particularly prone to bacterial infection and disease exacerbation and should receive lower doses. Interferon, when applied skillfully, induces the highly ...Continue Reading

References

Sep 2, 1976·The New England Journal of Medicine·H B GreenbergT C Merigan
Nov 30, 1989·The New England Journal of Medicine·G L DavisUNKNOWN Hepatitis Interventional Therapy Group
Nov 30, 1989·The New England Journal of Medicine·A M Di BisceglieJ H Hoofnagle
Nov 1, 1989·Seminars in Liver Disease·J H Hoofnagle, A M Di Bisceglie
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H HoofnagleH Popper
Nov 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A SmedileJ L Gerin
May 1, 1983·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J ScottoC Brechot
Feb 12, 1981·The New England Journal of Medicine·K C LamP C Wu

❮ Previous
Next ❯

Citations

May 1, 1994·Scandinavian Journal of Gastroenterology·J Wu, A Danielsson
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·C B Lamers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.